OVID
Ovid Therapeutics Inc.Pre-market2.19−0.22 −9.13%USD
NasdaqCM · as of Oct 13, 16:00 ET · 15m delay
Open
2.41
Prev close
2.41
Day range
2.182.42
52-week range
1.183.11
Volume
1.64M1.04×
Mkt cap
427.70M
P/E ttm
—
Fwd P/E
-5.84
EPS ttm
-0.2200
Div yield
0.00%
Earnings
Aug 13, 2026
From 52w high
−29.47%
OVID earnings and estimates
OVID Next Report
Yahoo Finance · Nasdaq
Report date
Wed, Nov 11
Before the open · estimated
EPS consensus
$−0.09
range −0.10 – −0.08
EPS growth vs year ago
+47.8%
year ago −0.17
Revenue consensus
$28.50K
−78.4% vs year ago
Options-implied move
±31.1%
by Nov 20 · ATM straddle
Past 4 reactions
±6.6%
average move · beat 2 of 4
EPS: Actual vs Estimate
Price Reaction
close before → close after the report
Recent Reports
| Quarter ending | Reported | EPS | Estimate | Surprise | Revenue | Next session | Five sessions |
|---|---|---|---|---|---|---|---|
| Jun '26 | Aug 13, 2026 BMO | −0.08 | −0.10 | +23.29% | — | +6.9% | +11.8% |
| Mar '26 | May 12, 2026 BMO | −0.12 | −0.11 | −13.21% | $0 | +2.9% | −13.6% |
| Dec '25 | Mar 18, 2026 BMO | 0.06 | −0.10 | +161.22% | $718.00K | +14.4% | +20.4% |
| Sep '25 | Nov 12, 2025 BMO | −0.17 | −0.15 | −14.86% | $132.00K | −2.2% | −2.2% |
Consensus Estimates and Revisions
| Period | EPS | Low · range · high | Growth | Revenue | Growth | 30d ago | 90d ago | Up / down (30d) |
|---|---|---|---|---|---|---|---|---|
| Current quarter Sep 2026 | −0.09 | −0.10−0.08 | +47.8% | $28.50K | −78.4% | −0.09 −0.2% | −0.11 +16.0% | 5 / 0 |
| Next quarter Dec 2026 | −0.09 | −0.11−0.08 | −256.3% | $82.08K | −88.6% | −0.10 +2.0% | −0.11 +14.8% | 6 / 0 |
| Current year Dec 2026 | −0.38 | −0.41−0.35 | −64.1% | $799.25K | −89.0% | −0.38 +1.0% | −0.44 +14.2% | 7 / 0 |
| Next year Dec 2027 | −0.38 | −0.50−0.29 | +0.7% | $186.08K | −76.7% | −0.40 +5.2% | −0.45 +17.0% | 4 / 1 |
The change columns show how the consensus has moved since then; steady upward revisions often precede beats. Ranges place the consensus between the lowest and highest analyst estimate.
Forward EPS Forecasts
Nasdaq · Zacks consensus
Quarterly
| Fiscal period | Consensus | Low · range · high | Analysts | Up / down (4w) |
|---|---|---|---|---|
| Sep 2026 | −0.08 | −0.10−0.05 | 7 | 0 / 0 |
| Dec 2026 | −0.09 | −0.11−0.08 | 7 | 0 / 0 |
| Mar 2027 | −0.09 | −0.10−0.08 | 4 | 0 / 0 |
| Jun 2027 | −0.09 | −0.11−0.07 | 4 | 0 / 0 |
| Sep 2027 | −0.09 | −0.12−0.07 | 4 | 0 / 0 |
Fiscal years
| Fiscal period | Consensus | Low · range · high | Analysts | Up / down (4w) |
|---|---|---|---|---|
| Dec 2026 | −0.37 | −0.41−0.35 | 8 | 0 / 0 |
| Dec 2027 | −0.38 | −0.53−0.29 | 8 | 0 / 0 |
| Dec 2028 | −0.42 | −0.65−0.28 | 4 | 0 / 0 |
| Dec 2029 | −0.31 | −0.49−0.16 | 4 | 0 / 0 |
Reactions run from the last close before a report to the first close after it (an after-the-close report is measured to the next day's close). The implied move is the at-the-money straddle for the first expiry after the report, the same rule as the bot's lgf emove.